
CMA Approves Legal Action Against Saudi German Health Board Over Revenue Inflation
Saudi Arabia's market regulator has accepted a request to pursue legal action against board members of Saudi German Health for reporting unearned revenues, allowing investors to join a class action lawsuit.
- The Capital Market Authority accepted an investor's request to sue board and audit committee members for inflating revenue.
- The company incorrectly recognized SAR358 million in unearned gross revenues between December 2018 and September 2021.
- Investors holding shares from March 24, 2019, to March 30, 2022, have 90 days to join the lawsuit.
Saudi Arabia’s Capital Market Authority has accepted a request for legal proceedings against certain members of the board and audit committee at Middle East Healthcare Company. This regulatory move follows an application by an investor alleging that the healthcare provider, which operates primarily under the Saudi German Health brand, inflated its reported revenue. The regulator confirmed that the company had recognized unearned gross revenues amounting to SAR358 million, equivalent to $95 million, in its financial records.
According to the Capital Market Authority, these unearned revenues were unlikely to be collected, leading to inaccurate financial statements. The period affected by these reporting errors spanned from December 31, 2018, through September 30, 2021.
Investors who held the company’s shares during the window from March 24, 2019, to March 30, 2022, are eligible to participate in the class action lawsuit. The Capital Market Authority stated that these investors have a 90-day period starting from the November 19 announcement to join the legal proceedings.
In recent financial reporting, Saudi German Health indicated a 14 percent year-on-year increase in revenue and posted an attributable net profit of SAR37 million for the third quarter of 2026. The share price has declined by more than 22 percent year-to-date. This development occurs as the Capital Market Authority continues to implement initiatives aimed at strengthening disclosure and transparency between listed companies and their investors, including requirements for biannual earnings calls.



